94 related articles for article (PubMed ID: 3679289)
1. In vivo H-2K and H-2D antigen expression in two allogeneic mouse tumours of low immunogenicity.
Ashley MP; Kotlarski I
Immunol Cell Biol; 1987 Aug; 65 ( Pt 4)():323-8. PubMed ID: 3679289
[TBL] [Abstract][Full Text] [Related]
2. In vivo reexpression of H-2 antigens in B16 melanoma cells.
Lollini PL; Colombo MP; De Giovanni C; Nicoletti G; Parmiani G; Prodi G; Nanni P
Exp Clin Immunogenet; 1985; 2(1):14-23. PubMed ID: 3939971
[TBL] [Abstract][Full Text] [Related]
3. Defects in tumor cell immunogenicity: lymphokine signals in in vitro cytolytic responses to tumor alloantigens.
Ashley MP; Kotlarski I; Vari F
Cell Immunol; 1987 Apr; 106(1):151-62. PubMed ID: 3568144
[TBL] [Abstract][Full Text] [Related]
4. The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells.
Eisenbach L; Hollander N; Greenfeld L; Yakor H; Segal S; Feldman M
Int J Cancer; 1984 Oct; 34(4):567-73. PubMed ID: 6490207
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
Li M; Muller J; Xu F; Hearing VJ; Gorelik E
Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142
[TBL] [Abstract][Full Text] [Related]
6. MHC antigens expressed on 3LL metastatic variants: correlation with the expression of a TSP-180 protein.
Sacchi A; Falcioni R; Tibursi G; Apollonj Ghetti C
Adv Exp Med Biol; 1988; 233():141-50. PubMed ID: 3223380
[TBL] [Abstract][Full Text] [Related]
7. Imbalance of MHC class I expression in 3LL tumour cells.
Benihoud K; Lecerf JM; Bobé P; Kiger N
Eur J Immunogenet; 1991; 18(5-6):355-65. PubMed ID: 1772880
[TBL] [Abstract][Full Text] [Related]
8. Immunity to B16 melanoma in mice immunized with IL-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens.
Kim TS; Russell SJ; Collins MK; Cohen EP
Int J Cancer; 1992 May; 51(2):283-9. PubMed ID: 1533203
[TBL] [Abstract][Full Text] [Related]
9. MHC antigen expression by melanomas recovered from mice treated with allogeneic mouse fibroblasts genetically modified for interleukin-2 secretion and the expression of melanoma-associated antigens.
Kim TS; Cohen EP
Cancer Immunol Immunother; 1994 Mar; 38(3):185-93. PubMed ID: 8124687
[TBL] [Abstract][Full Text] [Related]
10. Anti-metastatic effect by in vivo administration of concanavalin A through augmentation of T-derived activated killer activity: efficacy to B16 melanoma expressed MHC antigen.
Taniguchi K; Kawano YI; Toshitani A; Karashima A; Nomoto K
Cell Immunol; 1989 May; 120(2):460-9. PubMed ID: 2785862
[TBL] [Abstract][Full Text] [Related]
11. Loss of expression of transplantation antigens encoded by the H-2K locus on Lewis lung carcinoma cells and its relevance to the tumor's metastatic properties.
Isakov N; Katzav S; Feldman M; Segal S
J Natl Cancer Inst; 1983 Jul; 71(1):139-45. PubMed ID: 6345878
[TBL] [Abstract][Full Text] [Related]
12. Growth and metastasis in allogeneic hosts. Lack of H-2-negative or somatic hybrid variant selection.
De Giovanni C; Lollini PL; Nicoletti G; Del Re B; Scotlandi K; Prodi G; Nanni P
Exp Clin Immunogenet; 1987; 4(3):153-62. PubMed ID: 3273420
[TBL] [Abstract][Full Text] [Related]
13. Nucleotide sequences of three H-2K and three H-2D complementary DNA clones coding mouse class I MHC heavy chain proteins.
Wang M; Stepkowski SM; Hebert JS; Tian L; Yu J; Kahan BD
Ann Transplant; 1996; 1(3):26-31. PubMed ID: 9869916
[TBL] [Abstract][Full Text] [Related]
14. Decline in MHC class I expression with increasing thickness of cutaneous melanomas in standard-strain transgenic mouse models.
Milling SW; Silvers WK; Sai T; Mintz B
Melanoma Res; 2002 Jun; 12(3):221-30. PubMed ID: 12140378
[TBL] [Abstract][Full Text] [Related]
15. H-2Kb transfection of B16 melanoma cells results in reduced tumourigenicity and metastatic competence.
Porgador A; Feldman M; Eisenbach L
J Immunogenet; 1989; 16(4-5):291-303. PubMed ID: 2639904
[TBL] [Abstract][Full Text] [Related]
16. Expression of a transfected H-2Kb gene in B16 cells correlates with suppression of liver metastases in triple immunodeficient mice.
Calorini L; Marozzi A; Byers HR; Waneck GL; Lee KW; Isselbacher KJ; Gattoni-Celli S
Cancer Res; 1992 Jul; 52(14):4036-41. PubMed ID: 1617680
[TBL] [Abstract][Full Text] [Related]
17. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
18. Loss of the H-2.33 private specificity by 3LL tumor cells correlates with the tumor potential to metastasize across the H-2K region genetic barriers.
Isakov N; Feldman M; Segal S
Exp Clin Immunogenet; 1984; 1(3):170-4. PubMed ID: 6401004
[TBL] [Abstract][Full Text] [Related]
19. Restoration of MHC class I surface expression and endogenous antigen presentation by a molecular chaperone.
Wells AD; Rai SK; Salvato MS; Band H; Malkovsky M
Scand J Immunol; 1997 Jun; 45(6):605-12. PubMed ID: 9201299
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth.
Campbell I; Moyana T; Carlsen S; Zheng C; Xiang J
Cancer Gene Ther; 2000 Jan; 7(1):37-44. PubMed ID: 10678354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
